Life Science Company News

Results 381 - 400 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »

Better Choice Company Board of Directors Authorize Stock Repurchase Program

Read more ››
By: GlobenewsWire - 12 May 2022

Invectys appoints Timothy Papp as its Chief Financial Officer

Read more ››
By: GlobenewsWire - 12 May 2022

GBT Announces Five Data Presentations on Sickle Cell Disease at Upcoming EHA2022 Congress

Read more ››
By: GlobenewsWire - 12 May 2022

Cogent Biosciences Announces Presentation at European Hematology Association (EHA) Annual Congress

Read more ››
By: GlobenewsWire - 12 May 2022

Agios to Present Clinical and Translational Data at the European Hematology Association Annual Congress

Read more ››
By: GlobenewsWire - 12 May 2022

Aptose to Hold KOL Event and Corporate Update Thursday, June 2nd

Read more ››
By: GlobenewsWire - 12 May 2022

Genmab Announces Multiple Abstracts to be Presented at the European Hematology Association (EHA) Annual Congress

Read more ››
By: GlobenewsWire - 12 May 2022

Kronos Bio’s Investigational SYK Inhibitors Entospletinib and Lanraplenib to be Featured in Four Poster Presentations at EHA2022 Congress

Read more ››
By: GlobenewsWire - 12 May 2022

Novartis data at ASCO and EHA showcase latest oncology research and innovation, including in breast and prostate cancer

Read more ››
By: GlobenewsWire - 12 May 2022

Affimed to Present Preclinical Data Demonstrating Cytotoxic Activity of its Novel Innate Cell Engager AFM28 at the Annual Meeting of the European Hematology Association (EHA)

Read more ››
By: GlobenewsWire - 12 May 2022

CRISPR Therapeutics Announces Oral Presentation of New Clinical Data on Anti-CD70 Allogeneic CAR-T Therapy CTX130™ for Patients with T-cell Lymphoma at the Annual European Hematology Association (EHA) 2022 Hybrid Congress

Read more ››
By: GlobenewsWire - 12 May 2022

Mustang Bio Announces Results from Follicular Lymphoma Cohort of Ongoing Phase 1/2 Clinical Trial of MB-106, CD20-Targeted CAR T Therapy, Selected for Oral Presentation at European Hematology Association 2022 Hybrid Congress

Read more ››
By: GlobenewsWire - 12 May 2022

CORRECTION: Evelo Biosciences Announces First Quarter 2022 Financial Results and Business Highlights

Read more ››
By: GlobenewsWire - 12 May 2022

Autolus Therapeutics to Present Four Clinical Data Updates at the European Hematology Association Congress

Read more ››
By: GlobenewsWire - 12 May 2022

Preat Corporation & Panthera Dental Work Together to Bring Exceptional Metal Implant Bars to Dental Industry

Read more ››
By: GlobenewsWire - 12 May 2022

Apellis Announces Seven Abstracts in PNH to be Presented at the European Hematology Association Congress

Read more ››
By: GlobenewsWire - 12 May 2022

Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities

Read more ››
By: GlobenewsWire - 12 May 2022

CURE Pharmaceutical Announces Positive Findings from Study at Cincinnati Children’s Hospital Medical Center (CCHMC) Using CURE’s Proprietary, Oral Thin Film (OTF) High, Single Dose Vitamin D in Pediatric Patients Pre- and Post-Hematopoietic Stem Cell

Read more ››
By: GlobenewsWire - 12 May 2022

AltruBio Announces Completion of Enrollment in Phase 1 Clinical Study of Neihulizumab (ALTB-168) in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)

Read more ››
By: GlobenewsWire - 12 May 2022

GenScript ProBio Establishes Korean Legal Entity and Further Strengthens Cooperation in South Korea and APAC Region

Read more ››
By: PR Newswire Association LLC. - 12 May 2022
Results 381 - 400 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »

Enhance your business development with Biotechgate